Elevated levels of endothelial markers including CD31 were reported in COVID‐19 (Birnhuber et al., 2021), and temporary stress triggers CD31+ microparticle release (Lichtenauer et al., 2015). The gene discussed is PECAM1; the disease is COVID-19.